Domov › Areata alopecija › Indiana
Klinične študije za Areata alopecija v Indiana
8 študij za Areata alopecija išče udeležence na lokacijah v Indiana.
Mesta v Indiana
Uradno besedilo študije (angleško)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dawes Fretzin- Indianapolis /ID# 283498, Indianapolis
Vključevanje udeležencevFaza 3
Starost 6–17 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT07772492A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 18. sep. 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- Dawes Fretzin Clinical Research Group, Indianapolis
Vključevanje udeležencevFaza 1
Starost 18–70 · Vsi spoli · Posodobljeno 15. sep. 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 10. sep. 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Indiana University Health University Hospital /ID# 259827, Indianapolis
Vključevanje udeležencevFaza 3
Starost 12–63 · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT06012240A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
Vključevanje udeležencevFaza 3
Starost 6–14 · Vsi spoli · Posodobljeno 28. apr. 2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
- Options Research Group, West Lafayette
Vključevanje udeležencevFaza 1/2
Starost 18–55 · Vsi spoli · Posodobljeno 4. mar. 2026 · NCT06826196Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Ds Research - Indiana, Clarksville
- Dawes Fretzin Clinical Research Group Llc., Indianapolis
Vključevanje udeležencevFaza 3
Starost 12–17 · Vsi spoli · Posodobljeno 28. jan. 2026 · NCT07133308Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.